BioVie Files Routine 8-K, Confirms Nasdaq Listing
Ticker: BIVIW · Form: 8-K · Filed: Jan 19, 2024 · CIK: 1580149
| Field | Detail |
|---|---|
| Company | Biovie Inc. (BIVIW) |
| Form Type | 8-K |
| Filed Date | Jan 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $0, $25,000,000 million, $59.4 million, $1.8 m |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: administrative, corporate-governance, exchange-listing
TL;DR
**BioVie's 8-K is just a standard administrative update, nothing new for investors.**
AI Summary
This 8-K filing from BioVie Inc. on January 19, 2024, is a routine administrative update, primarily confirming its status as a publicly traded company on The Nasdaq Stock Market, LLC under the trading symbol BIVI. It also lists the company's business address in Carson City, NV, and its telephone number (775-888-3162). This filing is largely procedural and does not contain new financial or operational news, meaning it has minimal direct impact on current or prospective shareholders.
Why It Matters
This filing is purely administrative, confirming basic company information and its listing on Nasdaq. It does not contain any new material information that would typically influence investment decisions.
Risk Assessment
Risk Level: low — This 8-K filing is purely administrative and does not introduce any new financial, operational, or legal risks to the company or its investors.
Analyst Insight
A smart investor would recognize this 8-K as a routine administrative filing with no new material information, thus requiring no immediate action or change in investment thesis for BioVie Inc. (BIVI).
Key Numbers
- $0.0001 — Par value per share (This is the nominal par value for BioVie Inc.'s Class A Common Stock.)
Key Players & Entities
- BioVie Inc. (company) — the registrant filing the 8-K
- The Nasdaq Stock Market, LLC (company) — the exchange where BioVie's Class A Common Stock is registered
- BIVI (company) — the trading symbol for BioVie Inc.
- Carson City, NV (location) — BioVie Inc.'s principal executive offices
- January 19, 2024 (date) — date of earliest event reported and filing date
- 001-39015 (other) — Commission File Number
- 46-2510769 (other) — I.R.S. Employer Identification No.
- Nevada (location) — State of Incorporation for BioVie Inc.
- 680 W Nye Lane Suite 201 (location) — Street address of BioVie Inc.
- 89703 (location) — Zip Code of BioVie Inc.'s principal executive offices
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is BioVie Inc.
On which stock exchange is BioVie Inc.'s Class A Common Stock registered?
BioVie Inc.'s Class A Common Stock, with a par value of $0.0001 per share, is registered on The Nasdaq Stock Market, LLC under the trading symbol BIVI.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is January 19, 2024.
What is the business address and telephone number of BioVie Inc.?
BioVie Inc.'s business address is 680 W Nye Lane Suite 201, Carson City, NV 89703, and its telephone number is (775) 888-3162.
What is BioVie Inc.'s state or other jurisdiction of incorporation?
BioVie Inc.'s state of incorporation is Nevada.
Filing Stats: 728 words · 3 min read · ~2 pages · Grade level 9.6 · Accepted 2024-01-19 17:15:31
Key Financial Figures
- $0.0001 — tered Class A Common Stock, par value $0.0001 per share BIVI The Nasdaq Stock Marke
- $0 — ompanys Class A common stock, par value $0.0001, having an aggregate offering pric
- $25,000,000 million — , having an aggregate offering price of $25,000,000 million (the Shares). As of January 19, 2024,
- $59.4 million — s Agreement for a total net proceeds of $59.4 million after commissions and expenses of appro
- $1.8 m — mmissions and expenses of approximately $1.8 million, pursuant to a shelf registration
Filing Documents
- bivi-20240119_8k.htm (8-K) — 38KB
- bivi-20240119_8kex5z1.htm (EX-5.1) — 21KB
- image_001.jpg (GRAPHIC) — 22KB
- image_002.jpg (GRAPHIC) — 5KB
- 0001520138-24-000034.txt ( ) — 272KB
- bivi-20240119.xsd (EX-101.SCH) — 3KB
- bivi-20240119_lab.xml (EX-101.LAB) — 33KB
- bivi-20240119_pre.xml (EX-101.PRE) — 22KB
- bivi-20240119_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 19, 2024 BIOVIE INC. By: /s/ Joanne Wendy Kim Name: Joanne Wendy Kim Title: Chief Financial Officer